>> BUY NOW <<
Coreg

Coreg (generic name: Carvedilol; brand names: Dilatrend / Eucardic / Carloc) is a non-selective beta blocker.

Carvedilol is clinically proven to reduce morbidity and mortality in certain patients with heart failure and after a recent heart attack, and it is widely used to control high blood pressure. As a combined beta- and alpha-1–adrenergic blocker, it lowers blood pressure by decreasing heart rate and contractility while relaxing blood vessels. This dual action reduces the heart’s workload, improves cardiac efficiency, and helps protect the heart over time. For many patients, Coreg becomes a cornerstone therapy alongside other guideline-directed medical treatments such as ACE inhibitors/ARBs/ARNIs, diuretics, mineralocorticoid receptor antagonists, and SGLT2 inhibitors.

Coreg is approved to:

– Help those with heart failure live longer and stay out of the hospital
– Reduce the risk of death after a heart attack that weakened the heart’s pumping function
– Treat hypertension (high blood pressure), often in combination with other medications when a single drug is not enough

While effective, Coreg is a prescription medication that should be initiated and adjusted by a clinician who can monitor blood pressure, heart rate, symptoms, and drug interactions. Never start, stop, or change the dose without professional guidance.

How Coreg Works and Who It’s For

Coreg blocks beta-1 and beta-2 receptors in the heart and blood vessels, which slows the heart rate and decreases the force of contraction, thereby lowering oxygen demand. It also blocks alpha-1 receptors in arterial smooth muscle, causing vasodilation that reduces systemic vascular resistance. This combination lowers blood pressure and eases strain on the heart. Carvedilol also exhibits antioxidant and anti-proliferative properties, which may confer additional cardiac protection.

Indications where Coreg is commonly used include:

  • Chronic heart failure with reduced ejection fraction (HFrEF), typically New York Heart Association class II–III; it may be considered in stable class IV as tolerated.
  • Post–myocardial infarction with left ventricular dysfunction to reduce mortality and reinfarction risk when clinically stable.
  • Hypertension, either as monotherapy or combined with agents like thiazide diuretics, calcium channel blockers, ACE inhibitors, or ARBs when more intensive control is needed.

Coreg is often not the first-line agent for uncomplicated hypertension, but it is helpful when there are compelling cardiac indications (e.g., heart failure, prior MI) or when other therapies are insufficient. In heart failure, it is part of the core regimen that improves survival and quality of life.

Recommendations: How to Take Coreg Safely

Always follow your prescriber’s instructions. The dose and schedule are individualized and typically increased slowly to minimize side effects.

Key administration tips:

  • Take Coreg with food to reduce the risk of dizziness and low blood pressure, especially after the first doses or dose increases.
  • Immediate-release carvedilol is usually taken twice daily; the extended-release formulation (Coreg CR) is taken once daily in the morning with food. Do not crush or chew extended-release capsules.
  • If you have difficulty swallowing, ask your pharmacist whether your specific extended-release capsule can be carefully opened and the contents sprinkled on soft food; not all generics allow this—follow the product’s instructions.
  • Be consistent with timing to maintain steady levels and blood pressure control.

Missed dose:

  • If you miss a dose, take it when you remember unless it is near the time of your next dose. If it is close, skip the missed dose and resume your regular schedule. Do not take two doses at once.

Do not stop suddenly:

  • Never stop Coreg abruptly. Sudden discontinuation can precipitate chest pain, severe increases in blood pressure, arrhythmias, or worsening heart failure. If discontinuation is necessary, your clinician will taper the dose gradually.

Storage:

  • Store at room temperature, protected from moisture and excessive heat. Keep out of reach of children and pets.

Precautions and Contraindications

Before starting Coreg, discuss your full medical history and medication list with your clinician. Particular caution is warranted if you have:

  • Asthma or chronic obstructive pulmonary disease (COPD) with a history of bronchospasm. Non-selective beta-blockade can worsen wheezing. Select patients with mild COPD may still be candidates under close supervision; patients with reactive airway disease often require alternatives.
  • Bradycardia (low heart rate), certain heart blocks, sick sinus syndrome, or decompensated heart failure requiring inotropic support. Coreg can further slow conduction and heart rate.
  • Severe hepatic impairment. Carvedilol is metabolized in the liver; dose adjustments or avoidance may be necessary.
  • Diabetes or risk of hypoglycemia. Beta blockers can mask hypoglycemia symptoms such as tremor and palpitations, making blood sugar monitoring even more important.
  • Peripheral vascular disease or Raynaud’s phenomenon. Beta blockade can exacerbate cold extremities.
  • Thyroid disease. Beta blockers can mask tachycardia, a key sign of thyrotoxicosis.
  • Psoriasis, as beta blockers can rarely worsen cutaneous symptoms.
  • History of severe allergic reactions. Beta blockers may reduce the response to epinephrine in anaphylaxis.
  • Recent or upcoming surgery. Anesthesia interactions can affect blood pressure and heart rate; never stop beta blockers perioperatively without guidance.

Pregnancy and breastfeeding:

  • Pregnancy: Use only if the potential benefit justifies the potential risk. Uncontrolled hypertension or heart disease poses risks to both mother and fetus; management should be individualized by specialists.
  • Lactation: Carvedilol is present in small amounts in breast milk. Discuss risks and benefits with your healthcare provider.

Common and Serious Side Effects

Many side effects are mild and improve as your body adjusts or as the dose is titrated carefully. Contact your clinician if side effects are persistent or severe.

Common effects:

  • Dizziness or lightheadedness, especially when standing up quickly (orthostatic hypotension)
  • Fatigue, weakness, or drowsiness
  • Slower heart rate
  • Headache
  • Cold hands or feet
  • Digestive issues such as nausea or diarrhea
  • Weight gain or mild fluid retention, particularly early in heart failure therapy

Serious but less common effects requiring prompt medical attention:

  • Worsening shortness of breath, swelling of legs/ankles, rapid weight gain (possible heart failure decompensation)
  • Fainting, severe dizziness, or very slow heartbeat
  • Wheezing or bronchospasm
  • Severe allergic reaction: rash, hives, swelling of face/lips/tongue, difficulty breathing
  • Yellowing of the skin or eyes, dark urine, persistent nausea (possible liver issues)
  • Mood changes or depression

In people with diabetes, watch for changes in blood sugar control. Coreg may mask adrenergic symptoms of low blood sugar; monitor glucose regularly and carry a rapid source of sugar.

Drug and Food Interactions

Carvedilol has important interactions that can affect heart rate, blood pressure, and drug levels. Share all prescription medicines, over-the-counter products, and supplements with your clinician and pharmacist.

  • Other heart rate–lowering drugs: Combining with diltiazem, verapamil, digoxin, or amiodarone can increase risk of bradycardia or heart block. Digoxin levels may rise with carvedilol; monitor and adjust as needed.
  • Antihypertensives and vasodilators: Additive effects with ACE inhibitors, ARBs, nitrates, alpha-blockers, and PDE5 inhibitors (e.g., sildenafil) may cause symptomatic hypotension.
  • Clonidine: If both are used, changes must be carefully managed to avoid rebound hypertension; do not stop clonidine abruptly while on a beta blocker.
  • Insulin and oral diabetes medicines: Beta blockers may potentiate hypoglycemia and mask its symptoms; monitor closely.
  • CYP2D6 inhibitors: Drugs like fluoxetine, paroxetine, quinidine, and bupropion can increase carvedilol levels; dose adjustments may be necessary.
  • Strong inhibitors or inducers of P-glycoprotein and CYP pathways: May alter carvedilol exposure; consult your pharmacist.
  • NSAIDs: Can blunt the antihypertensive effects of many agents and affect kidney function when combined with diuretics/ACE inhibitors.
  • Alcohol: Can amplify dizziness and blood pressure–lowering effects. Use caution.

Dietary considerations: Maintain a consistent sodium intake if you have heart failure, follow your clinician’s guidance on fluid limits, and avoid sudden changes in caffeine or alcohol intake that may affect heart rate or blood pressure.

Monitoring and Follow-Up

Effective and safe Coreg use relies on regular monitoring, especially during initiation and dose titration.

  • Blood pressure and heart rate: Check at home and in clinic. Contact your clinician if resting heart rate drops below the individualized target or if you experience symptomatic hypotension.
  • Weight and symptoms: Weigh daily if you have heart failure. Report rapid weight gain (e.g., 2–3 pounds in a day or 5 pounds in a week) or increased swelling/shortness of breath.
  • Blood glucose: Monitor more frequently if you have diabetes, particularly when the dose changes.
  • Liver function: Periodic liver tests may be recommended for those with underlying hepatic concerns or if symptoms suggest liver issues.

Who Should Not Take Coreg?

Absolute or relative contraindications include:

  • Severe bradycardia, second- or third-degree AV block without a pacemaker
  • Sick sinus syndrome without a pacemaker
  • Cardiogenic shock or decompensated heart failure requiring inotropes
  • Severe hepatic impairment
  • History of bronchospastic disease where non-selective beta blockade is unsafe
  • Known hypersensitivity to carvedilol or any component of the formulation

Coreg vs. Coreg CR and Other Beta Blockers

Coreg is available as immediate-release twice-daily tablets and as once-daily extended-release capsules (Coreg CR). The total daily dose is not always a 1:1 conversion when switching between formulations; your clinician will choose equivalent dosing based on the product labeling and your response. Do not switch products without guidance.

Compared with selective beta-1 blockers like metoprolol, carvedilol’s alpha-1 blockade provides additional vasodilation, which can be advantageous in heart failure and certain hypertensive profiles. Choice of agent depends on your cardiac condition, comorbidities, blood pressure, heart rate, and tolerability.

Patient Tips for Success

  • Rise slowly from sitting or lying positions to reduce lightheadedness.
  • Take with food consistently to improve tolerability.
  • Keep a blood pressure and heart rate log; bring it to appointments.
  • Maintain a heart-healthy lifestyle: low-sodium eating pattern, regular physical activity as approved by your clinician, smoking cessation, and stress management.
  • Carry a medication list and let all healthcare providers know you are on a beta blocker, especially before surgeries or dental procedures.

Ingredients

Active ingredient: carvedilol.
Inactive ingredients vary by manufacturer and may include lactose, cellulose derivatives, povidone, silicon dioxide, magnesium stearate, and capsule components in extended-release products. If you have allergies or intolerances, review the specific product’s package insert or ask your pharmacist to help identify a suitable formulation.

Important Safety Notes for Special Populations

  • Older adults: More sensitive to blood pressure–lowering effects; slower dose titration may be needed.
  • Black patients with hypertension: As with many beta blockers, carvedilol monotherapy may be less effective for blood pressure compared with other classes; combination therapy is commonly used. In heart failure, carvedilol remains beneficial across populations.
  • Kidney disease: Carvedilol is primarily hepatically metabolized; however, careful monitoring is advised in advanced kidney disease due to concomitant medications and fluid balance considerations.
  • Liver disease: Dose reductions or alternative therapies may be required. Avoid in severe hepatic impairment.

Overdose and Emergency Information

Symptoms of overdose may include profound dizziness, fainting, very slow heart rate, trouble breathing, seizures, or shock. If an overdose is suspected, call emergency services immediately. Supportive care in a medical setting may include intravenous fluids, atropine for bradycardia, glucagon, vasopressors, and other interventions as clinically indicated.

Availability and Cost Considerations

Carvedilol is widely available as a generic in multiple strengths for both immediate-release and extended-release formulations, generally at low cost through retail and mail-order pharmacies. Prices vary by dosage form, insurer, and pharmacy. Many patients find significant savings through prescription discount programs or insurance formularies. Always verify the formulation and strength to avoid accidental switching between immediate-release and extended-release products without clinician guidance.

Professional Guidance on Titration

Titration is central to achieving Coreg’s benefits in heart failure. Clinicians typically start at low doses and up-titrate every 1–2 weeks as tolerated, monitoring blood pressure, heart rate, weight, and symptoms. Dose ceilings depend on patient weight, comorbidities, and response. If side effects develop, the dose may be reduced temporarily and up-titrated more slowly. Collaboration between patient and care team is essential to reach target doses shown to reduce hospitalizations and improve survival.

What Sets Coreg Apart

Coreg’s combined beta and alpha-1 blockade differentiates it from many beta-1–selective agents, providing additional vasodilation and afterload reduction. In heart failure, carvedilol has robust evidence supporting improved outcomes when added to optimized background therapy. Its role after myocardial infarction with reduced ejection fraction further underscores its cardioprotective profile.

Coreg U.S. Sale and Prescription Policy

In the United States, Coreg (carvedilol) is a prescription-only medication regulated by the FDA. By law, pharmacies may dispense it only pursuant to a valid prescription issued by a licensed healthcare professional after an appropriate evaluation. Purchasing carvedilol without a prescription is not permitted under U.S. federal and state regulations.

HealthSouth Rehabilitation Hospital at Martin supports patients by facilitating lawful, structured access to care. Patients can be connected with licensed healthcare providers for appropriate evaluation, diagnosis, and, when clinically indicated, a prescription for Coreg that can be filled through accredited, compliant pharmacies. This approach ensures safety, effectiveness, and adherence to all applicable regulations. If you believe Coreg may be right for you, consult a qualified clinician or use a reputable telehealth service for a medical assessment and individualized treatment plan.

Coreg FAQ

What is Coreg (carvedilol) and what conditions does it treat?

Coreg is a prescription beta-blocker with additional alpha-1 blocking activity. It’s used to treat high blood pressure, heart failure with reduced ejection fraction, and left ventricular dysfunction after a heart attack. It can also help control heart rate in certain arrhythmias under a clinician’s guidance.

How does Coreg work in the body?

Carvedilol blocks beta-1 and beta-2 receptors to slow the heart rate and reduce the heart’s workload, and it blocks alpha-1 receptors to relax blood vessels. This combination lowers blood pressure and helps the heart pump more efficiently.

What are the common side effects of Coreg?

Common side effects include dizziness, fatigue, slow heart rate, low blood pressure (especially when standing), diarrhea, and weight gain or fluid retention. Some people notice cold hands/feet or sexual dysfunction. Most effects are mild, but contact your clinician if symptoms are severe or persistent.

How should I take Coreg for best results?

Take Coreg with food to reduce the risk of dizziness and orthostatic hypotension. Take it at the same times each day as prescribed. Do not stop suddenly; tapering is needed to avoid rebound heart issues.

What is the difference between Coreg and Coreg CR?

Coreg is the immediate-release tablet taken twice daily, while Coreg CR is an extended-release capsule taken once daily. The milligram strengths are not directly interchangeable; clinicians use specific conversion doses when switching.

What starting dose is typical for Coreg?

Doses are individualized. In heart failure, a common starting dose is 3.125 mg twice daily, gradually increased as tolerated. For hypertension, many start at 6.25 mg twice daily with careful up-titration.

Can Coreg cause weight gain or swelling?

Yes, fluid retention and mild weight gain can occur, especially in heart failure. Report new or worsening swelling in your legs, ankles, or sudden weight gain, as your diuretic or Coreg dose may need adjustment.

What should I do if I miss a dose of Coreg?

If it’s been only a few hours, take it when you remember. If it’s close to your next dose, skip the missed dose and resume your usual schedule. Do not double up to catch up.

Are there people who should not take Coreg?

Avoid Coreg if you have severe liver impairment, severe bradycardia, second- or third-degree heart block without a pacemaker, decompensated heart failure requiring IV inotropes, or a history of serious bronchospasm from beta-blockers. Use caution with asthma/COPD, diabetes, and peripheral vascular disease.

Does Coreg interact with other medications?

Yes. Drugs that slow heart rate (like diltiazem, verapamil, digoxin) can increase the risk of bradycardia or heart block. CYP2D6 inhibitors (fluoxetine, paroxetine, quinidine) can raise carvedilol levels; clonidine, other antihypertensives, and alcohol can enhance hypotension. Coreg can increase digoxin concentrations; monitoring may be needed.

How long does it take for Coreg to start working?

Blood pressure effects are seen within hours to days. In heart failure, benefits build gradually over weeks to months as doses are titrated and the heart remodels.

Can Coreg affect blood sugar?

Yes. Carvedilol can mask symptoms of low blood sugar (like fast heartbeat) and may alter glucose control. Monitor blood sugars closely if you have diabetes, especially when starting or adjusting the dose.

Is dizziness normal when starting Coreg?

Dizziness and lightheadedness are common when beginning therapy or increasing the dose, especially when standing up. Taking doses with food and rising slowly from sitting or lying can help.

Can I crush or open Coreg tablets or capsules?

Do not crush or chew Coreg tablets. Coreg CR capsules can be swallowed whole or opened and sprinkled on applesauce for immediate use; do not chew the pellets and do not take with hot liquids.

What happens if I stop Coreg abruptly?

Stopping suddenly can cause rebound tachycardia, hypertension, angina, or even heart attack in high-risk patients. Always taper under medical supervision.

Can I drink alcohol while taking Coreg?

Alcohol can amplify Coreg’s blood-pressure–lowering effects and increase dizziness or fainting, especially when standing. Limit or avoid alcohol, particularly when starting treatment or changing doses.

Is Coreg safe during pregnancy?

Data in pregnancy are limited. Beta-blockers may be associated with fetal growth restriction and neonatal bradycardia or hypoglycemia. Use only if clearly needed and under specialist guidance.

Can I breastfeed while taking Coreg?

Human data are limited, though carvedilol’s high protein binding suggests low transfer into milk. Safer beta-blockers (like labetalol, metoprolol, or propranolol) are often preferred during breastfeeding; if carvedilol is used, monitor the infant for poor feeding, sleepiness, or bradycardia.

What should I do about Coreg before surgery or anesthesia?

If you’re already on Coreg, it’s usually continued through surgery to reduce cardiac risk. Inform your surgical and anesthesia teams; they’ll monitor for low blood pressure or slow heart rate and adjust medications as needed. Do not start or stop on the day of surgery without medical advice.

Is it okay to take Coreg after a night of heavy drinking?

Heavy alcohol intake raises the risk of pronounced hypotension, dizziness, and falls when combined with Coreg. Skip binge drinking, hydrate, and if you feel unwell or lightheaded, hold activities that require alertness and contact your clinician for personalized guidance.

Can I drive or operate machinery on Coreg?

Until you know how Coreg affects you, avoid driving or hazardous tasks. If you experience dizziness, fatigue, or blurry vision, wait until these resolve.

What should people with asthma or COPD know about Coreg?

Carvedilol blocks beta-2 receptors and can provoke bronchospasm. In patients with reactive airway disease, it should be avoided or used with extreme caution, and selective beta-1 blockers may be safer alternatives.

How does Coreg compare with metoprolol?

Metoprolol is beta-1 selective, while Coreg blocks beta-1, beta-2, and alpha-1 receptors. Coreg tends to lower blood pressure more via vasodilation and may be preferred in certain heart failure patients; metoprolol succinate also has strong heart failure evidence and may be better tolerated in patients with bronchospasm risk.

Coreg versus bisoprolol: which is better for heart failure?

Both have proven mortality benefits in HFrEF. Bisoprolol is beta-1 selective and may be better for patients prone to bronchospasm or peripheral vasospasm, while Coreg’s alpha-1 blockade may offer additional blood pressure lowering and anti-ischemic effects. Choice depends on comorbidities and tolerance.

How does Coreg compare to atenolol for blood pressure?

Atenolol is older, beta-1 selective, and typically once daily, but it has less robust cardiovascular outcome data compared with other agents. Coreg’s mixed beta/alpha blockade can provide stronger BP reduction and broader heart failure benefits, though it may cause more dizziness initially.

Coreg vs nebivolol: what’s the difference?

Nebivolol is a highly beta-1 selective blocker with nitric oxide–mediated vasodilation, often associated with fewer sexual side effects and good BP control. Coreg provides additional alpha-1 blockade and strong evidence in HFrEF across a wide age range. Nebivolol may be an option when selectivity and tolerability are priorities.

Is Coreg or labetalol better for hypertension?

Both block beta and alpha-1 receptors. Labetalol is frequently preferred for pregnancy-related hypertension and acute BP management, while Coreg is commonly used chronically, especially when heart failure or post-MI indications are present. Individual factors guide the choice.

Coreg versus propranolol: which should I use?

Propranolol is nonselective and penetrates the brain, making it useful for migraine prevention, essential tremor, and performance anxiety. Coreg is optimized for cardiovascular indications like heart failure and hypertension, with additional alpha-1 blockade for BP lowering.

How does Coreg compare with metoprolol succinate (extended-release) in heart failure?

Both improve survival in HFrEF. Some studies suggest carvedilol may reduce hospitalizations or provide stronger BP lowering due to alpha-1 blockade, while metoprolol succinate may be preferable in patients with airway disease or who need beta-1 selectivity. Either is reasonable when titrated to target doses.

Is Coreg better than metoprolol tartrate?

In heart failure, metoprolol tartrate (immediate-release) is not the preferred formulation; metoprolol succinate (extended-release) has outcome data. Carvedilol has shown advantages over tartrate in some trials; guideline-supported options for HFrEF are carvedilol, bisoprolol, and metoprolol succinate.

Coreg vs sotalol: are they interchangeable?

No. Sotalol is an antiarrhythmic with class III properties used for atrial and ventricular arrhythmias and carries a risk of torsades de pointes. Coreg is used for BP and heart failure; they serve different roles and are not substitutes.

How does Coreg compare to nadolol?

Nadolol is a long-acting nonselective beta-blocker often used for portal hypertension and migraine prevention. Coreg also reduces portal pressure and may be used off-label in liver disease, but it is primarily chosen for heart failure and hypertension, with added alpha-1 blockade for vasodilation.

Should I choose Coreg or a cardioselective beta-blocker if I have diabetes?

Carvedilol can improve insulin sensitivity relative to some selective beta-blockers, but it also masks hypoglycemia symptoms. Cardioselective agents (like metoprolol or bisoprolol) may be favored if bronchospasm risk is present. Discuss glucose goals, hypoglycemia risk, and comorbidities with your clinician.

Coreg CR vs once-daily beta-blockers like nebivolol or atenolol: which is easier?

Coreg CR offers once-daily dosing similar to nebivolol or atenolol. However, side-effect profiles and indications differ; Coreg CR retains carvedilol’s mixed blockade and heart failure benefits, while nebivolol/atenolol provide beta-1 selectivity that some patients tolerate better.

Can Coreg be used for atrial fibrillation rate control compared with metoprolol?

Yes, carvedilol can slow ventricular rate in AF, similar to metoprolol. Metoprolol is often first-line due to beta-1 selectivity, while carvedilol may be chosen when blood pressure reduction is also desired or in patients with concomitant heart failure.

Is switching from metoprolol to Coreg straightforward?

Switching requires careful dose conversion and monitoring for heart rate, blood pressure, and symptoms. Because carvedilol adds alpha-1 blockade, patients may experience more initial dizziness; clinicians typically start low and up-titrate.

Can Coreg be taken with PDE5 inhibitors like sildenafil compared with other beta-blockers?

All beta-blockers can interact with PDE5 inhibitors to lower blood pressure, and carvedilol’s alpha-1 blockade may enhance this effect slightly. Space doses apart, start with the lowest PDE5 inhibitor dose, and monitor for dizziness.

Does Coreg have any advantages over other beta-blockers after a heart attack?

Carvedilol reduces mortality and reinfarction risk in post-MI patients with left ventricular dysfunction. Its combined beta and alpha-1 effects can improve afterload reduction, though metoprolol and other evidence-based beta-blockers also provide strong post-MI benefits. The best choice depends on individual tolerance and comorbidities.